Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol vs Aspirin for Stroke Prevention
NCT00202020Phase 3Completed
- Sponsor
- Otsuka Holdings
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cilostazol in cerebral infarction, sponsored by Otsuka Holdings. Started May 2004; status: completed.
02
Drugs
cilostazol
03
Conditions
cerebral infarction
Beyond the preview
Go deeper on NCT00202020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00202020.